HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1/S transition via IgD receptor activity.

Abstract
The aim of the present study was to investigate the role and molecular mechanism of human IgD (hIgD) on the proliferation of human Burkitt lymphoma Daudi cells in vitro. Logarithmically growing Daudi cells were treated with hIgD for different time periods, and cell proliferation was evaluated by cell counting kit-8 (CCK-8) assay. The expressions of Daudi surface markers and IgD receptor (IgDR) as well as cell cycle and apoptosis were measured by flow cytometry analysis. Our results showed that hIgD stimulation induced proliferation and IgDR expression and reduced the apoptosis of Daudi cells. Treatment with hIgD promoted progression of the cell cycle at the G1/S transition, and this was accompanied by upregulation of c-myc, cyclin D3, and CDK6 as well as downregulation of p16 mRNA and protein levels. Moreover, hIgD treatment also upregulated the expression of tyrosine phosphorylation of 70 kDa protein (IgDR) and p-Lyn. Taken together, these results indicate that hIgD can induce Daudi cell proliferation through activating IgDR to initiate the tyrosine phosphorylation signaling cascade to accelerate the G1/S transition.
AuthorsXing Dai, YuJing Wu, XiaoYi Jia, Yan Chang, HuaXun Wu, Chun Wang, HengShi Chen, WenSheng Chen, Qiong Huang, Wei Wei
JournalImmunologic research (Immunol Res) Vol. 64 Issue 4 Pg. 978-87 (08 2016) ISSN: 1559-0755 [Electronic] United States
PMID26724941 (Publication Type: Journal Article)
Chemical References
  • CDKN2A protein, human
  • Cyclin D3
  • Cyclin-Dependent Kinase Inhibitor p16
  • Immunoglobulin D
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
  • Receptors, Fc
  • immunoglobulin D receptor
  • CDK6 protein, human
  • Cyclin-Dependent Kinase 6
Topics
  • Burkitt Lymphoma (immunology, pathology, therapy)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cyclin D3 (metabolism)
  • Cyclin-Dependent Kinase 6 (metabolism)
  • Cyclin-Dependent Kinase Inhibitor p16 (genetics, metabolism)
  • G1 Phase Cell Cycle Checkpoints
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunoglobulin D (metabolism)
  • Immunotherapy (methods)
  • Molecular Targeted Therapy
  • Phosphorylation
  • Proto-Oncogene Proteins c-myc (metabolism)
  • Receptors, Fc (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: